Novartis AG is 235.5x more valuable than Avalyn Pharma Inc. by market capitalization ($282.64 B vs $1.20 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AVLN | NVS |
|---|---|---|
| Market cap | $1.20 B | $282.64 B |
| US-listed rank | #2503 | #47 |
| SEC filings | 51 | 947 |
Novartis AG is 235.5x more valuable than Avalyn Pharma Inc. by market capitalization ($282.64 B vs $1.20 B).
Full pages: Avalyn Pharma Inc. and Novartis AG, or browse the full rankings.